Hindustan Agrigenetics Achieves Profitability in FY26 on Higher Revenue

Hindustan Agrigenetics reports FY26 profit of ₹0.13 crore on ₹1.05 crore revenue.
Company turns around from a loss of ₹0.30 crore in FY25.

Reader Takeaway: Profitability achieved with revenue growth, but driven by one-time land sale gain.

What just happened

Hindustan Agrigenetics Limited has announced its audited financial results for the year ended March 31, 2026. The company reported an annual profit of ₹0.1342 crore (₹13.42 lakh) on a total revenue of ₹1.0515 crore (₹105.15 lakh). This marks a significant turnaround from the previous fiscal year, FY2025, when the company posted a loss of ₹-0.3050 crore (₹-30.50 lakh) on revenue of ₹0.8370 crore (₹83.70 lakh).

Why this matters

The shift from a net loss to a net profit is a crucial development for shareholders. The revenue growth of approximately 25% year-on-year indicates an expansion in business activity. However, investors need to understand the composition of the profit, as a substantial part of it comes from an exceptional item – the profit on the sale of agricultural land amounting to ₹0.1332 crore (₹13.32 lakh).

The backstory

In the fiscal year 2025, Hindustan Agrigenetics was in a loss-making position. The current fiscal year's results show a recovery in performance, with improved revenue and a positive bottom line. The company's financial statements for FY2026 received an unmodified opinion from its statutory auditors, M/s. Anant Rao & Mallik.

What changes now

The company has also focused on governance by appointing Mr. V. R. Sridharan as the Internal Auditor for the financial year 2026-2027, effective May 30, 2026. This appointment is a routine governance measure and does not directly impact the operational financials but aims to strengthen internal controls.

Risks to watch

A key watch point for investors is the reliance on exceptional items for profitability. The profit on sale of agricultural land significantly bolsters the net profit, meaning core operations alone may not yet be consistently profitable. Additionally, the company reported revaluation losses on financial assets, which impacted the bottom line. Investors should monitor the sustainability of profits and the impact of financial asset volatility.

Peer comparison

(No peer comparison data available in the filing.)

Context metrics (time-bound)

• FY2026 Revenue: ₹1.0515 crore (up from ₹0.8370 crore in FY2025)
• FY2026 Profit: ₹0.1342 crore (up from ₹-0.3050 crore in FY2025)
• Exceptional Item (Land Sale Gain): ₹0.1332 crore in FY2026

What to track next

Investors should closely track the company's revenue growth from its core agricultural genetics business in the upcoming quarters. Monitoring the management's strategy to improve operational profitability and manage financial assets effectively will be crucial.